Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 2/20 | 1.00 |
| ▸ | LDHB | P07195 | 1/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 5/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 4/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxamate SCHEMBL11620 | 1.00 | — | — | |
| Oxamate SCHEMBL2558688 | 0.95 | — | — | |
| Oxamate SCHEMBL4394181 | 0.95 | — | — | |
| Oxamate SCHEMBL3888428 | 0.95 | — | — | |
| Oxamate SCHEMBL30360379 | 0.95 | — | — | |
| Oxamate SCHEMBL5710751 | 0.95 | LDHA (0.90) | LDHALDHBACHELMNATDP1 | |
| Oxamate SCHEMBL2541414 | 0.95 | — | — | |
| Oxamate SCHEMBL7757988 | 0.95 | LDHA (0.90) | LDHALDHBACHELMNATDP1 | |
| Oxamate SCHEMBL1258135 | 0.95 | — | — | |
| Oxamate SCHEMBL28760846 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-5137888-A | Side effect reduction | BAZZANO GAIL S (US) | 1992-08-11 | — | — | US | claimed |
| EP-0387831-A2 | Resin composition curable at low temperature | NIPPON PAINT CO., LTD. (JP) | 1990-09-19 | — | — | EP | claimed |
| WO-1989007595-A1 | SPIROAZA DERIVATIVES OF HETEROCYCLIC N-OXIDES AND THEIR USE IN HAIR GROWTH PROMOTION | BAZZANO GAIL S (US) | 1989-08-24 | — | — | WO | claimed |
| WO-1989006234-A1 | N,N-SUBSTITUTED AMINES AND USE THEREOF IN HAIR GROWTH PROMOTION | BAZZANO GAIL S (US) | 1989-07-13 | — | — | WO | claimed |
| CN-117384061-B | Dioxamine hapten, antigen, antibody, detection device and preparation and application thereof | 深圳市通量检测科技有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-117384061-A | Dioxamine hapten, antigen, antibody, detection device and preparation and application thereof | 深圳市通量检测科技有限公司 | 2024-01-12 | — | — | CN | disclosed |
| US-20220047505-A1 | Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration | STI PHARMA, LLC (US) | 2022-02-17 | — | — | US | disclosed |
| US-11191719-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2021-12-07 | — | — | US | disclosed |
| US-10463611-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2019-11-05 | — | — | US | disclosed |
| US-3982006-A | PROPHYLAXIS, ANTIALLERGY, ANTIANAPHYLACTIC | THE UPJOHN COMPANY (US) | 1976-09-21 | — | — | US | disclosed |
| US-3980660-A | ANTIAUERGENS, ANAPHYLACTIC | THE UPJOHN COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
| US-3972911-A | PROPHYLAXIS | THE UPJOHN COMPANY (US) | 1976-08-03 | — | — | US | disclosed |
| US-3963660-A | ANTI-ALLERGY | THE UPJOHN COMPANY (US) | 1976-06-15 | — | — | US | disclosed |
| US-3962308-A | Process for converting esters to amine salts | THE UPJOHN COMPANY (US) | 1976-06-08 | — | — | US | disclosed |